Novartis Pharmaceuticals recalls

5 official recalls and safety alerts involving Novartis Pharmaceuticals since 2022-06, from FDA · Drug. Newest first. Check the official notice for exact models and batch codes.

This list only includes recalls Recall Atlas has collected since 2021-10. A product not listed here may still be affected; check with Novartis Pharmaceuticals or the relevant agency.

  1. 2026-08-19
  2. US
  3. 2023-12-13
  4. US
    Drugs & medicalClass I

    Novartis Pharmaceuticals Corporation recalls SANDIMMUNE Oral Solution (cyclosporine oral solution, USP) 100 mg/mL, 50 mL bottle, Rx Only, Manufactured by: DELPHARM…

    Crystallization: bottles of Sandimmune Oral Solution were determined to contain crystals

    FDA · DrugNovartis Pharmaceuticals CorporationNationwide within the United StatesOfficial notice →
  5. 2023-09-27
  6. US
    Drugs & medicalClass I

    Novartis Pharmaceuticals Corp. recalls SANDIMMUNE Oral Solution (cyclosporine oral solution, USP) 100 mg/mL, 50 mL bottle, Rx Only, Manufactured by: DELPHARM Huningue…

    Crystallization: bottles of Sandimmune Oral Solution were determined to contain crystals.

    FDA · DrugNovartis Pharmaceuticals Corp.Nationwide in the USAOfficial notice →
  7. 2022-10-05
  8. US
    Drugs & medicalClass II

    Novartis Pharmaceuticals Corporation recalls Neoral soft gelatin capsules (cyclosporine capsules, USP) Modified, 25 mg, Rx Only, 30 Soft Gelatin Capsules per carton,…

    CGMP deviations: Out of specification results obtained during routine stability testing for ethanol content.

    FDA · DrugNovartis Pharmaceuticals CorporationNationwide and Puerto RicoOfficial notice →
  9. 2022-06-15
  10. US
    Drugs & medicalClass III

    Novartis Pharmaceuticals Corporation recalls Xiidra (lifitegrast ophthalmic solution) 5% PROFESSIONAL SAMPLE, packaged in a) 5 single-use containers (0.2 mL each vial)…

    Failed Impurities/Degradation Specifications.

    FDA · DrugNovartis Pharmaceuticals CorporationNationwide within the United StatesOfficial notice →